Ruggieri, Pietro
Azienda Ospedale Università Padova,
Italy
2025 Rank: 87,691
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 432 out of 91,178 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87,691 | 88,604 |
| Total Cites | 1,306 | 1,422 |
| H-index | 15 | 16 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 77 | 86 |
| Number of Single+First+Last Authored Papers | 258 | 258 |
| Total Cites to Single+First+Last Authored Papers | 591 | 649 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,000 | 1,048 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
8.16%
|
|
Ruggieri, Pietro
Università degli Studi di Padova,
Italy
2024 Rank: 92,334
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 464 out of 83,175 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,334 | 76,603 |
| Total Cites | 1,236 | 1,388 |
| H-index | 12 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 1 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 78 | 87 |
| Number of Single+First+Last Authored Papers | 237 | 237 |
| Total Cites to Single+First+Last Authored Papers | 580 | 656 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 957 | 1,008 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.38 |
| Self-Citation Percentage |
10.95%
|
|
Ruggieri, Pietro
Università degli Studi di Padova,
Italy
2023 Rank: 86,084
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 473 out of 77,248 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86,084 | 91,958 |
| Total Cites | 1,166 | 1,282 |
| H-index | 14 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 91 | 94 |
| Number of Single+First+Last Authored Papers | 224 | 224 |
| Total Cites to Single+First+Last Authored Papers | 542 | 581 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 888 | 933 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
9.05%
|
|
Ruggieri, Pietro
Università degli Studi di Padova,
Italy
2022 Rank: 84,256
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 465 out of 71,530 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84,256 | 87,963 |
| Total Cites | 1,058 | 1,171 |
| H-index | 15 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 109 | 120 |
| Number of Single+First+Last Authored Papers | 198 | 198 |
| Total Cites to Single+First+Last Authored Papers | 479 | 528 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 847 | 898 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
9.65%
|
|
Ruggieri, Pietro
Università degli Studi di Padova,
Italy
2021 Rank: 91,414
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 576 out of 67,782 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,414 | 94,248 |
| Total Cites | 1,432 | 1,568 |
| H-index | 18 | 20 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 164 | 165 |
| Number of Single+First+Last Authored Papers | 183 | 183 |
| Total Cites to Single+First+Last Authored Papers | 670 | 712 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,107 | 1,176 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
8.67%
|
|
Ruggieri, Pietro
Università degli Studi di Padova,
Italy
2020 Rank: 109,689
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Orthopedics
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 658 out of 57,183 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109,689 | 121,499 |
| Total Cites | 883 | 990 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 108 | 113 |
| Number of Single+First+Last Authored Papers | 166 | 166 |
| Total Cites to Single+First+Last Authored Papers | 423 | 468 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 673 | 726 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
10.81%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.